SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001104659-24-023111
Filing Date
2024-02-14
Accepted
2024-02-14 09:48:49
Documents
1
Group Members
JEROME G. PFUNDNEW EMERGING MEDICAL OPPORTUNITIES FUND III, L.P., AN EXEMPTED LIMITED PARTNERSHIP

Document Format Files

Seq Description Document Type Size
1 SC 13G/A tm246006d1_sc13ga.htm SC 13G/A 70588
  Complete submission text file 0001104659-24-023111.txt   72417
Mailing Address 1010 SHERBROOKE ST., WEST SUITE 1610 MONTREAL A8 H3A 2R7
Business Address 1010 SHERBROOKE ST., WEST SUITE 1610 MONTREAL A8 H3A 2R7 514 849 8777
SECTORAL ASSET MANAGEMENT INC (Filed by) CIK: 0001274413 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8
Type: SC 13G/A

Mailing Address 142 NORTH CEDROS AVENUE, SUITE B SOLANA BEACH CA 92075
Business Address 142 NORTH CEDROS AVENUE, SUITE B SOLANA BEACH CA 92075 (858) 925-8215
eFFECTOR Therapeutics, Inc. (Subject) CIK: 0001828522 (see all company filings)

IRS No.: 853306396 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-91982 | Film No.: 24633283
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)